Article citationsMore>>

Jackson, G., et al. (2010) Counterfeit phosphodisterase type 5 inhibitors pose significant safety risks. International Journal of Clinical Practice, 64, 497-504.
http://dx.doi.org/10.1111/j.1742-1241.2009.02328.x

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top